Latest Active B12 Test Companies Update
Nov 2023: The application of artificial intelligence (AI) in healthcare services is a wager made by Siemens Healthineers, a German provider of healthcare solutions and services. Siemens Healthineers has over 800 AI-related patents and has created 84 AI-enabled products. To guarantee security, every application undergoes rigorous testing and validation. The company offers products like "Syngo Carbon" that can analyze data from a wide range of medical devices, not just their own. Additionally, it has produced several AI applications, including digital twins for the liver and heart and the AI RAD companion for radiography. The use of AI in healthcare is beginning to increase in India. According to Mangsuli, artificial intelligence (AI) is utilized in blood testing for early diagnosis based on pathology results and radiology to improve diagnosis efficiency.
Feb 2023: For a cash price of $46.5 million, Diasorin SpA sold Cytek Biosciences Inc. its Flow Cytometry and Imaging (FCI) business unit. That represents a significant decrease from the $75 million that Luminex Corp., a Diasorin affiliate, paid Milleporesigma for the FCI assets 2018. Within 30 days, the firms anticipate that the sale will close.
List of Active B12 Test Key companies in the market
- Axis Shield Diagnostics Ltd.,
- Abbott,
- Siemens Healthcare Private Limited.,
- DiaSorin S.p.A.,
- Hoffmann La Roche Ltd.,
- LifeSpan BioSciences, Inc.,
- Demeditec GmbH